Unlocking the healthcare value chain: 2nd regional workshop on manufacturing Active Pharmaceutical Ingredients and excipients in Nigeria
![](https://nafdac.gov.ng/wp-content/uploads/2024/07/API-Cover-for-website-1024x300.jpg)
Introduction Active Pharmaceutical Ingredients (APIs) are the essential components of pharmaceutical products responsible for the intended therapeutic effect.They form the backbone of pharmaceutical formulation and their quality directly impacts the safety and efficacy of the medicines which directly impacts public health. The National Agency for Food and Drug Administration and control (NAFDAC) has recognised the […]
Regional Workshop on ICH Q1 – Stability Guideline (22nd – 24th July, 2024)
![](https://nafdac.gov.ng/wp-content/uploads/2024/07/ICH-latest-cover-1024x300.png)
Public Notice No. 026/2024 – Notice to Uninstall and Reinstall Med Safety App Important Update for Med Safety App Users
Dear Valued Users, We hope this message finds you well. We are excited to announce that several important updates have been rolled out for the Med Safety App, enhancing its functionality and user experience. These updates include vital bug fixes and improvements that have been developed and deployed over the years. To ensure you receive […]
Public Alert No. 025/2024 – Alert on the Sale of Counterfeit PHESGO 600mg/10ml Injection in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) wishes to inform healthcare providers and the public of a report of a suspected counterfeit of Phesgo® 600mg/600mg, labeled with batch C3809C51. The Marketing Authorization Holder (MAH) Roche received a complaint from a pharmacist reporting a suspected counterfeit Phesgo® 600mg/600mg, labeled with batch C3809C51. […]
Public Alert No. 024/2024 – Alert on Recall of Herbal Dietary Supplement by Stop-Clopez Corp. Due to Undeclared Nortadalafil
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of a voluntary recall of one lot of Schwinnng capsules by Stop Clopex Corp, due to the undeclared presence of Nortadalafil. The product was found to contain Nortadalafil, during an FDA analysis. Nortadalafil is an active drug ingredient known for […]